Ocrelizumab (marketed as Ocrevus) is now on the PBS list in Australia.
That means that it is now available for $A39.50 per script compared to $A$35,100 per year previously.
Multiple sclerosis wonderdrug gets government subsidy
Admins, I mistakenly posted this in the wrong forum - it belongs in the MS forum. Can you move it there please. Thanks.